GRPR-targeted cancer imaging efficiency of iron oxide nanoparticles is being investigated to a slightly lower extent than gold nanoparticles, but, considering their clinical success [101], they still pose a great importance in contemporary cancer management, especially in bioimaging of malignant tumors. Here, GRPR is linked to cancer.